ELGX - Endologix, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 55.95M
Enterprise value 3160.99M
Trailing P/E N/A
Forward P/E 1-0.13
PEG ratio (5-yr expected) 10.00
Price/sales (ttm)0.04
Price/book (mrq)0.11
Enterprise value/revenue 31.18
Enterprise value/EBITDA 6-4.03

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 3-95.65%
S&P500 52-week change 35.09%
52-week high 37.2000
52-week low 30.2300
50-day moving average 30.8438
200-day moving average 31.0499

Share statistics

Avg vol (3-month) 31.24M
Avg vol (10-day) 39.56M
Shares outstanding 519.17M
Float 14.15M
% held by insiders 14.69%
% held by institutions 174.71%
Shares short (14 Jun 2020) 4236.45k
Short ratio (14 Jun 2020) 40.46
Short % of float (14 Jun 2020) 41.39%
Short % of shares outstanding (14 Jun 2020) 41.23%
Shares short (prior month 14 May 2020) 4255.57k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 305 Mar 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Mar 2020

Profitability

Profit margin -44.65%
Operating margin (ttm)-33.99%

Management effectiveness

Return on assets (ttm)-9.82%
Return on equity (ttm)-167.38%

Income statement

Revenue (ttm)136.27M
Revenue per share (ttm)7.07
Quarterly revenue growth (yoy)-19.90%
Gross profit (ttm)91.09M
EBITDA -39.97M
Net income avi to common (ttm)-60.84M
Diluted EPS (ttm)-3.1570
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)40.85M
Total cash per share (mrq)2.14
Total debt (mrq)195.94M
Total debt/equity (mrq)367.45
Current ratio (mrq)0.39
Book value per share (mrq)2.79

Cash flow statement

Operating cash flow (ttm)-25.23M
Levered free cash flow (ttm)-16.94M